Nuocheng Jianhua Nanjing R&D Center was awarded the title of "Specialized, Refined, Unique and New"

On January two, two thousand twenty-five, Nuocheng Jianhua Nanjing R&D Center was awarded the title of "Specialized, Refined, Unique and New" Small and Medium sized Enterprise. Beijing, China - Nuocheng Jianhua, a biopharmaceutical high-tech company (Shanghai Stock Exchange code: six hundred and eighty-eight thousand four hundred and twenty-eight; Hong Kong Stock Exchange code: nine thousand nine hundred and sixty-nine), announced today that Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd. has recently been awarded the title of "two thousand twenty-four Provincial Specialized, Refined, Unique and New Small and Medium sized Enterprise" in Jiangsu Province. This is a full recognition of the technical capabilities, innovation capabilities, professionalism, and market position of the Nanjing R&D center of Nuocheng Jianhua. Specialized, refined, distinctive, and innovative small and medium-sized enterprises refer to leading enterprises that focus on segmented markets, have strong innovation capabilities, high market share, master key core technologies, and excellent quality and efficiency. Nuocheng Jianhua Nanjing R&D Center is located in Gaoxin Park, Jiangning District, Nanjing City. It has strong R&D capabilities and has been providing new drug research and development, as well as technical consulting and transfer services for many years. At present, the R&D laboratory covers an area of three thousand three hundred and fifty square meters and has been recognized as a high-tech enterprise, Nanjing Engineering Research Center, and Nanjing Engineering Technology Research Center. Dr. Cui Jisong, co-founder, chairman, and CEO of Nuocheng Jianhua, said, "Under the guidance of the concept of 'science driven innovation', Nuocheng Jianhua has always adhered to the spirit of entrepreneurship and innovation, and is fully promoting the research and development of innovative drugs and the transformation of achievements. We are pleased to see that our innovation strength has once again been recognized by local governments and experts. Our companies in Beijing, Guangzhou, and Nanjing have all been awarded the title of 'specialized, refined, unique, and new'. We will continue to deeply cultivate source innovation, continuously improve, specialize, and strengthen on the road of new drug research and development, and make unremitting efforts to benefit patients worldwide." (Nuocheng Jianhua)